mitazalimab-arkiv - BioStock

BiBBInstruments strong Q2

Alligator’s CEO: “We are not surprised by the positive readout”

3 March, 2025

BioStock Investor Pitch: Alligator Bioscience

3 February, 2025

Alligator’s CEO: “I’m confident that we will strike a deal”

30 January, 2025

Alligator rights issue 2025

Alligator’s CEO: “We are on track to secure a partnership”

10 December, 2024

Alligator Q3 2024

Robust data drives Alligator Bioscience forward

30 October, 2024

Alligator_CFO

Alligator brings in new CFO ahead of phase III

3 September, 2024

Alligator Fas II-data

“Unprecedented” phase II data for Alligator in pancreatic cancer

3 July, 2024

SørenBregenholt, CEO AlligatorBioscience

Alligator meets primary endpoint with CD40 agonist in pancreatic cancer

31 January, 2024

Alligator_Strong_Q3

Strong Q3 performance for Alligator Bioscience

2 November, 2023

Alligator Bioscience

Alligator Bioscience’s CSO presents CD40 portfolio at summit

14 July, 2023

12 3 Page 1 of 3